$5.9 Billion Worldwide Antibody Drug Conjugates Industry to 2031 - Identify Growth Segments for Investment
22 mars 2022 05h28 HE
|
Research and Markets
Dublin, March 22, 2022 (GLOBE NEWSWIRE) -- The "Antibody Drug Conjugates Global Market Report 2022: By Type, By Application, By Product, By Technology, By End-User" report has been added to...
Global Cancer Antibody Drug Conjugate Markets, Forecast to 2028 - Sales Trends; Clinical Insights; Dosage, Price & Patent Insights; Quarterly & Yearly Drug Sales; Competitive Landscape and More
02 mars 2022 06h13 HE
|
Research and Markets
Dublin, March 02, 2022 (GLOBE NEWSWIRE) -- The "Global Cancer Antibody Drug Conjugate Market, Drug Sales, Price, & Clinical Trials Insight 2028" report has been added to ResearchAndMarkets.com's...
Antibody Drug Conjugates (ADCs) Market Size to Reach USD 13.17 Billion by 2028 - Powered by Approval for Biologics License Applications – Vantage Market Research
15 févr. 2022 04h39 HE
|
Vantage Market Research
WASHINGTON, Feb. 15, 2022 (GLOBE NEWSWIRE) -- Vantage Market Research’s recent analysis of the Global Antibody Drug Conjugates (ADCS) Market finds that granted accelerated approval for biologics...
Genmab and Synaffix Enter into License Agreement for ADC Technology
04 janv. 2022 09h00 HE
|
Genmab A/S
Media Release Synaffix to provide access to proprietary antibody-drug conjugate (ADC) technologiesGenmab secures rights for conducting research on ADCs against multiple drug targets with options for...
Global Antibody Drug Conjugates Contract Manufacturing Market (2021 to 2028) - Featuring Lonza, Catalent and Siegfried Among Others
02 nov. 2021 08h48 HE
|
Research and Markets
Dublin, Nov. 02, 2021 (GLOBE NEWSWIRE) -- The "Antibody Drug Conjugates Contract Manufacturing Market Size, Share & Trends Analysis Report By Condition (Myeloma, Lymphoma, Breast Cancer), By...
Global Antibody Drug Conjugates Market Research 2021 Featuring Major Players - Bayer, Concortis Biotherapeutics, F. Hoffman-La Roche, Immunomedics, and Oxford BioTherapeutics
20 oct. 2021 09h23 HE
|
Research and Markets
Dublin, Oct. 20, 2021 (GLOBE NEWSWIRE) -- The "Antibody Drug Conjugates Global Market Report 2021: COVID-19 Growth and Change to 2030" report has been added to ResearchAndMarkets.com's offering. The...
Insights on the Antibody Drug Conjugates Global Market to 2030 - Featuring 6 Dimensions Capital, AbbVie and ABL Bio Among Others
08 oct. 2021 05h58 HE
|
Research and Markets
Dublin, Oct. 08, 2021 (GLOBE NEWSWIRE) -- The "Antibody Drug Conjugates Market by Indication, Linker, Payload, Target Antigens and Geography: Industry Trends and Global Forecasts, 2021-2030" report...
Worldwide Oncology Pharmaceuticals Industry to 2026 - Robust Approval of Oncology Pharmaceuticals is Driving Growth
06 oct. 2021 07h13 HE
|
Research and Markets
Dublin, Oct. 06, 2021 (GLOBE NEWSWIRE) -- The "Global Oncology Pharmaceuticals Market 2021-2026" report has been added to ResearchAndMarkets.com's offering. The global market for oncology...
Global $23.9 Billion Antibody Drug Conjugate Markets to 2028: Major Players are Entering into Partnerships for Development & Commercialization
16 sept. 2021 04h38 HE
|
Research and Markets
Dublin, Sept. 16, 2021 (GLOBE NEWSWIRE) -- The "Global Antibody Drug Conjugate Market" report has been added to ResearchAndMarkets.com's offering. The global antibody drug conjugate market size is...
Tasrif Pharmaceutical Announces Grant of U.S. Patent for Humanized Monoclonal Antibodies against the Poliovirus Receptor
25 août 2021 12h00 HE
|
Tasrif Pharmaceutical, LLC
BOSTON, Aug. 25, 2021 (GLOBE NEWSWIRE) -- Tasrif Pharmaceutical announces the grant of a US Patent related to its proprietary humanized monoclonal antibodies against the poliovirus receptor (a.k.a....